NO953072L - Anvendelse av inhibitorer av ornitinaminotransferase for fremstilling av et medikament for behandling av Alzheimers sykdom - Google Patents

Anvendelse av inhibitorer av ornitinaminotransferase for fremstilling av et medikament for behandling av Alzheimers sykdom

Info

Publication number
NO953072L
NO953072L NO953072A NO953072A NO953072L NO 953072 L NO953072 L NO 953072L NO 953072 A NO953072 A NO 953072A NO 953072 A NO953072 A NO 953072A NO 953072 L NO953072 L NO 953072L
Authority
NO
Norway
Prior art keywords
alzheimer
treatment
medicament
inhibitors
disease
Prior art date
Application number
NO953072A
Other languages
English (en)
Other versions
NO953072D0 (no
Inventor
Nikolaus Seiler
Jean-Bernard Ducep
Karin Camille Jund
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO953072L publication Critical patent/NO953072L/no
Publication of NO953072D0 publication Critical patent/NO953072D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Ny anvendelse av 5-substituerte ornitinderivater for fremstilling av et farmasøytisk preparat for behandling av demens av Alzheimers type.
NO953072A 1993-02-05 1995-08-04 Anvendelse av inhibitorer av ornitinaminotransferase for fremstilling av et medikament for behandling av Alzheimers sykdom NO953072D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93400303A EP0609630A1 (en) 1993-02-05 1993-02-05 Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of Alzheimer's disease
PCT/US1993/011283 WO1994017795A1 (en) 1993-02-05 1993-11-19 Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease

Publications (2)

Publication Number Publication Date
NO953072L true NO953072L (no) 1995-08-04
NO953072D0 NO953072D0 (no) 1995-08-04

Family

ID=8214677

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953072A NO953072D0 (no) 1993-02-05 1995-08-04 Anvendelse av inhibitorer av ornitinaminotransferase for fremstilling av et medikament for behandling av Alzheimers sykdom

Country Status (14)

Country Link
US (1) US5637768A (no)
EP (2) EP0609630A1 (no)
JP (1) JPH08506577A (no)
AU (1) AU682330B2 (no)
CA (1) CA2152796A1 (no)
FI (1) FI953725A0 (no)
HU (1) HUT73173A (no)
IL (1) IL107737A (no)
MX (1) MX9400911A (no)
NO (1) NO953072D0 (no)
NZ (2) NZ258461A (no)
TW (1) TW383337B (no)
WO (1) WO1994017795A1 (no)
ZA (1) ZA938836B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1448183A2 (en) * 2001-11-16 2004-08-25 ALS Therapy Development Foundation, Inc. Treatment of neurodegenerative disorders through the modulation of the polyamine pathway
JP2005510524A (ja) * 2001-11-16 2005-04-21 アルス・セラピー・デベロツプメント・フアンデーシヨン・インコーポレーテツド ポリアミン経路の調節による神経変性障害の治療
CN111362828A (zh) * 2020-03-30 2020-07-03 山西医科大学 一种18f标记的氟丙酰化鸟氨酸及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE77367T1 (de) * 1988-02-05 1992-07-15 Merrell Dow Pharma 5-substituierte ornithin-derivate.

Also Published As

Publication number Publication date
IL107737A (en) 1998-12-27
AU5614394A (en) 1994-08-29
JPH08506577A (ja) 1996-07-16
HUT73173A (en) 1996-06-28
CA2152796A1 (en) 1994-08-18
HU9502320D0 (en) 1996-05-28
ZA938836B (en) 1994-08-02
TW383337B (en) 2000-03-01
AU682330B2 (en) 1997-10-02
US5637768A (en) 1997-06-10
FI953725A (fi) 1995-08-04
MX9400911A (es) 1994-08-31
NZ258461A (en) 1997-03-24
FI953725A0 (fi) 1995-08-04
NZ280983A (en) 1997-07-27
WO1994017795A1 (en) 1994-08-18
EP0682515A1 (en) 1995-11-22
EP0609630A1 (en) 1994-08-10
NO953072D0 (no) 1995-08-04
IL107737A0 (en) 1994-02-27

Similar Documents

Publication Publication Date Title
NO2016005I1 (no) 2-okso-1-pyrrolidinderivater, farmasøytisk preparat og deres anvendelse for fremstilling av et medikament
NO962568D0 (no) Anvendelse av PLA2 inhibitorer som behandling for Alzheimers sykdom
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
ES2188584T3 (es) Derivados heterociclicos de amina.
TR199902071T2 (xx) Heterosiklik bile�ikler ve bunlar�n �-amilioid peptidinin inhibisyonunda kullan�m�
NO981911D0 (no) Anvendelse av rhodaninderivater for fremstilling av et medikament for behandling av Alzheimer's sykdom
NO20045434L (no) En kombinasjon av en NMDA-antagonist og acetylkolinesteraseinhibitorer for behandlingen av Alzheimers sykdom
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
NO952890D0 (no) Kombinasjonsbehandling for inhibisjon av bentap
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
NO20000771L (no) Anvendelse av fankinon for behandling av Alzheimers sykdom
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
HUP9802897A2 (hu) Optikailag aktív piridil-4H-1,2,4-oxadiazin-származék, annak alkalmazása vaszkuláris betegségek kezelésére, valamint ilyen származékot hatóanyagként tartalmazó gyógyászati készítmény
NO953072L (no) Anvendelse av inhibitorer av ornitinaminotransferase for fremstilling av et medikament for behandling av Alzheimers sykdom
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
HUP9701060A2 (hu) Darifenacint tartalmazó gyógyszerkészítmény kognitív zavarok kezelésére
GEP20043377B (en) Pharmaceutical Complex
MY133438A (en) Morpholinobenzamide salts
DK0703781T3 (da) Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom
ATE169922T1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
FR2673105B1 (fr) Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
BR9713044A (pt) Composto, uso de um composto, processo para sua preparação,e, formulação farmacêutica.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application